Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences 3D Culture Models

Jens Kelm's Biography



Jens Kelm, CEO and Co-Founder, PreComb Therapeutics AG

Jens M. Kelm, PhD is a biotech executive and co-inventor of 3D microtissue technology with more than 20 years of experience in Biotech. He got his PhD at the Institute of Biotechnology at the ETHZ followed by a research associate position at the University Hospital Zürich. After two years he became the scientific director of the Competence Center Applied Biotechnology and Molecular Medicine (CABMM) at the University of Zürich. He is a co-founder of InSphero AG where he served as CSO/CTO as well as chairman of the Board of Directors. Currently CEO and co-founder of PreComb Therapeutics AG applying 3D tissue engineering technologies to discover novel drug combinations. Jens has generated 10 patents/applications, published more than 50 scientific publications focusing on the development and implementation of 3D models in drug discovery and regenerative medicine. and is also co-founder and committee member of the competence center for Tissue engineering for Drug Development and substance Testing (TEDD).

Jens Kelm Image

Patient-specific Functional Prediction of Cancer Drug Efficacy

Thursday, 9 September 2021 at 11:15

Add to Calendar ▼2021-09-09 11:15:002021-09-09 12:15:00Europe/LondonPatient-specific Functional Prediction of Cancer Drug Efficacy3D Culture Models in Virtual Event - Eastern Daylight Time (EDT) ZoneVirtual Event - Eastern Daylight Time (EDT) ZoneSELECTBIOenquiries@selectbiosciences.com

In an effort to improve in vitro biology, tremendous progress has been made over the past decade in integrating cells into 3D dimensional configurations. While the various technologies for fabricating micro-physiology have improved significantly, the choice of the right cell type for each application remains. Cells as the building blocks for a 3D tissue model are an important determinant of its biological relevance. Here, I will present the current status to use patient-specific primary tumor cells as building blocks for 3D tumor models.


Add to Calendar ▼2021-09-09 00:00:002021-09-09 00:00:00Europe/London3D Culture Models3D Culture Models in Virtual Event - Eastern Daylight Time (EDT) ZoneVirtual Event - Eastern Daylight Time (EDT) ZoneSELECTBIOenquiries@selectbiosciences.com